Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S111-S134
Open Access | Times Cited: 448

Showing 1-25 of 448 citing articles:

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Ian H. de Boer, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2020) Vol. 98, Iss. 4, pp. S1-S115
Open Access | Times Cited: 962
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Weimar Kunz Sebba Barroso, Cibele Isaac Saad Rodrigues, Luiz Aparecido Bortolotto, et al.
Arquivos Brasileiros de Cardiologia (2021) Vol. 116, Iss. 3, pp. 516-658
Open Access | Times Cited: 787
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Sandeep R. Das, Brendan M. Everett, Kim K. Birtcher, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 9, pp. 1117-1145
Open Access | Times Cited: 352
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease
Guanghong Jia, James R. Sowers
Hypertension (2021) Vol. 78, Iss. 5, pp. 1197-1205
Open Access | Times Cited: 230
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 176
Ten things to know about ten cardiovascular disease risk factors
Harold Bays, Pam R. Taub, Elizabeth Epstein, et al.
American Journal of Preventive Cardiology (2021) Vol. 5, pp. 100149-100149
Open Access | Times Cited: 173
An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Leslie E. Kolb
The Science of Diabetes Self-Management and Care (2021) Vol. 47, Iss. 1, pp. 30-53
Open Access | Times Cited: 162
Diabetes Complications in Racial and Ethnic Minority Populations in the USA
J. Sonya Haw, Megha Shah, Sara Turbow, et al.
Current Diabetes Reports (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 158
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association
Janani Rangaswami, Vivek Bhalla, Ian H. de Boer, et al.
Circulation (2020) Vol. 142, Iss. 17
Open Access | Times Cited: 144
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
Lauren A. Eberly, Lin Yang, Utibe R. Essien, et al.
JAMA Health Forum (2021) Vol. 2, Iss. 12, pp. e214182-e214182
Open Access | Times Cited: 142
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer
Janelle Guirguis‐Blake, Corinne V. Evans, Leslie A Perdue, et al.
JAMA (2022) Vol. 327, Iss. 16, pp. 1585-1585
Open Access | Times Cited: 116
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, et al.
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 2991-2998
Open Access | Times Cited: 111
Glycemic variability and cardiovascular disease in patients with type 2 diabetes
M. Rodriguez Martinez, Jimena Santamarina, Adrián Pavesi, et al.
BMJ Open Diabetes Research & Care (2021) Vol. 9, Iss. 1, pp. e002032-e002032
Open Access | Times Cited: 107
National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
Rishav Adhikari, Kunal Jha, Zeina Dardari, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 88
Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association
Tak Kwan, Sally S. Wong, Yuling Hong, et al.
Circulation (2023) Vol. 148, Iss. 1, pp. 74-94
Closed Access | Times Cited: 55
Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health
Ivana Djuričić, Philip C. Calder
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 383-406
Open Access | Times Cited: 46
Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity
Erin D. Michos, Francisco López-Jiménez, Martha Gulati
Journal of the American Heart Association (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 43
DRAC 2022: A public benchmark for diabetic retinopathy analysis on ultra-wide optical coherence tomography angiography images
Bo Qian, Hao Chen, Xiangning Wang, et al.
Patterns (2024) Vol. 5, Iss. 3, pp. 100929-100929
Open Access | Times Cited: 42
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Valerie King, Susan B. Gurley, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 3, pp. 195-203
Open Access | Times Cited: 126
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Devinder S. Dhindsa, Pratik B. Sandesara, Michael D. Shapiro, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 123
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)
Aiping Wang, Guozhong Lv, Xingbo Cheng, et al.
Burns & Trauma (2020) Vol. 8
Open Access | Times Cited: 109
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Connie B. Newman, Michael J. Blaha, Jeffrey B. Boord, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3613-3682
Open Access | Times Cited: 105
Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: ThePIONEERprogramme
Tina K. Thethi, Richard E. Pratley, Juris J. Meier
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 8, pp. 1263-1277
Open Access | Times Cited: 100
GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
Thomas Karagiannis, Απόστολος Τσάπας, Eleni Athanasiadou, et al.
Diabetes Research and Clinical Practice (2021) Vol. 174, pp. 108737-108737
Closed Access | Times Cited: 98
Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent
M. Larissa Avilés‐Santa, Alberto Monroig-Rivera, Alvin Soto-Soto, et al.
Current Diabetes Reports (2020) Vol. 20, Iss. 11
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top